Theravance Biopharma Presents Additional Positive Phase 2b Study Data on TD-4208
May 20, 2015 at 08:06 AM EDT
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the presentation of additional ...